GB1479268A
(en)
|
1973-07-05 |
1977-07-13 |
Beecham Group Ltd |
Pharmaceutical compositions
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
GB1451798A
(en)
|
1973-08-02 |
1976-10-06 |
Ici Ltd |
Prostanoic acid derivatives
|
CH596313A5
(lt)
|
1975-05-30 |
1978-03-15 |
Battelle Memorial Institute |
|
US4385260A
(en)
|
1975-09-09 |
1983-05-24 |
Beckman Instruments, Inc. |
Bargraph display
|
US4414147A
(en)
|
1981-04-17 |
1983-11-08 |
Massachusetts Institute Of Technology |
Methods of decreasing the hydrophobicity of fibroblast and other interferons
|
JPS57206622A
(en)
|
1981-06-10 |
1982-12-18 |
Ajinomoto Co Inc |
Blood substitute
|
US4451566A
(en)
|
1981-12-04 |
1984-05-29 |
Spencer Donald B |
Methods and apparatus for enzymatically producing ethanol
|
US4438253A
(en)
|
1982-11-12 |
1984-03-20 |
American Cyanamid Company |
Poly(glycolic acid)/poly(alkylene glycol) block copolymers and method of manufacturing the same
|
EP0263533A3
(en)
|
1983-03-01 |
1990-05-30 |
C.R.C. Compagnia di Ricerca Chimica S.p.A. |
A method for preparing the cytidine monophosphate of 5-acetamido-3,5-dideoxy-d-glycero-d-galactononulosaminic acid
|
DE3308806A1
(de)
|
1983-03-12 |
1984-09-13 |
Basf Ag, 6700 Ludwigshafen |
Fungizide mittel, substituierte glucopyranosylamine und verfahren zur bekaempfung von pilzen
|
JPS59172425A
(ja)
|
1983-03-18 |
1984-09-29 |
Nippon Chemiphar Co Ltd |
新規な血液凝固因子誘導体およびその製造法ならびにそれを含有する血液凝固促進剤
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
US4565653A
(en)
|
1984-03-30 |
1986-01-21 |
Pfizer Inc. |
Acyltripeptide immunostimulants
|
US4879236A
(en)
|
1984-05-16 |
1989-11-07 |
The Texas A&M University System |
Method for producing a recombinant baculovirus expression vector
|
US4675414A
(en)
|
1985-03-08 |
1987-06-23 |
The United States Of America As Represented By The Secretary Of The Navy |
Maleimidomethyl-carbonate polyethers
|
GR860984B
(en)
|
1985-04-17 |
1986-08-18 |
Zymogenetics Inc |
Expression of factor vii and ix activities in mammalian cells
|
WO1987000056A1
(en)
|
1985-06-26 |
1987-01-15 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
JPS6238172A
(ja)
|
1985-08-12 |
1987-02-19 |
株式会社 高研 |
抗血栓性医用材料の製造方法
|
SE451849B
(sv)
|
1985-12-11 |
1987-11-02 |
Svenska Sockerfabriks Ab |
Sett att syntetisera glykosidiska bindningar samt anvendning av pa detta sett erhallna produkter
|
IT1213029B
(it)
|
1986-01-30 |
1989-12-07 |
Bracco Ind Chimica Spa |
Chelati di ioni metallici paramagnetici.
|
US4767702A
(en)
|
1986-02-06 |
1988-08-30 |
Cohenford Menashi A |
Paper strip assay for neisseria species
|
US4925796A
(en)
|
1986-03-07 |
1990-05-15 |
Massachusetts Institute Of Technology |
Method for enhancing glycoprotein stability
|
US5272066A
(en)
|
1986-03-07 |
1993-12-21 |
Massachusetts Institute Of Technology |
Synthetic method for enhancing glycoprotein stability
|
WO1987005330A1
(en)
|
1986-03-07 |
1987-09-11 |
Michel Louis Eugene Bergh |
Method for enhancing glycoprotein stability
|
US4902505A
(en)
|
1986-07-30 |
1990-02-20 |
Alkermes |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
IL82834A
(en)
|
1987-06-09 |
1990-11-05 |
Yissum Res Dev Co |
Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
|
US4847325A
(en)
|
1988-01-20 |
1989-07-11 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
US5153265A
(en)
|
1988-01-20 |
1992-10-06 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
GB8810808D0
(en)
|
1988-05-06 |
1988-06-08 |
Wellcome Found |
Vectors
|
US5169933A
(en)
|
1988-08-15 |
1992-12-08 |
Neorx Corporation |
Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
|
US5874261A
(en)
|
1988-09-02 |
1999-02-23 |
The Trustees Of The University Of Pennsylvania |
Method for the purification of glycosyltransferases
|
US5218092A
(en)
|
1988-09-29 |
1993-06-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
|
US5104651A
(en)
|
1988-12-16 |
1992-04-14 |
Amgen Inc. |
Stabilized hydrophobic protein formulations of g-csf
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
US6166183A
(en)
|
1992-11-30 |
2000-12-26 |
Kirin-Amgen, Inc. |
Chemically-modified G-CSF
|
DE68925966T2
(de)
|
1988-12-22 |
1996-08-29 |
Kirin Amgen Inc |
Chemisch modifizierte granulocytenkolonie erregender faktor
|
JP3162372B2
(ja)
|
1988-12-23 |
2001-04-25 |
ジェネンテク,インコーポレイテッド |
ヒトdnアーゼ
|
AU634517B2
(en)
|
1989-01-19 |
1993-02-25 |
Pharmacia & Upjohn Company |
Somatotropin analogs
|
EP0456642A1
(en)
|
1989-01-31 |
1991-11-21 |
The Upjohn Company |
Somatotropin analogs
|
US5194376A
(en)
|
1989-02-28 |
1993-03-16 |
University Of Ottawa |
Baculovirus expression system capable of producing foreign gene proteins at high levels
|
US5059535A
(en)
|
1989-04-12 |
1991-10-22 |
Chembiomed, Ltd. |
Process for the separation and purification of sialyl transferases
|
ES2247656T3
(es)
|
1989-04-19 |
2006-03-01 |
Enzon, Inc. |
Un proceso para formar un polipeptido modificado que comprende un polipeptido y un oxido de polialquileno.
|
US5324844A
(en)
|
1989-04-19 |
1994-06-28 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
US5166322A
(en)
|
1989-04-21 |
1992-11-24 |
Genetics Institute |
Cysteine added variants of interleukin-3 and chemical modifications thereof
|
US5342940A
(en)
|
1989-05-27 |
1994-08-30 |
Sumitomo Pharmaceuticals Company, Limited |
Polyethylene glycol derivatives, process for preparing the same
|
US5672683A
(en)
|
1989-09-07 |
1997-09-30 |
Alkermes, Inc. |
Transferrin neuropharmaceutical agent fusion protein
|
US5154924A
(en)
|
1989-09-07 |
1992-10-13 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
US5527527A
(en)
|
1989-09-07 |
1996-06-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical agent conjugates
|
US5182107A
(en)
|
1989-09-07 |
1993-01-26 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
US5977307A
(en)
|
1989-09-07 |
1999-11-02 |
Alkermes, Inc. |
Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
|
US5032519A
(en)
|
1989-10-24 |
1991-07-16 |
The Regents Of The Univ. Of California |
Method for producing secretable glycosyltransferases and other Golgi processing enzymes
|
US5312808A
(en)
|
1989-11-22 |
1994-05-17 |
Enzon, Inc. |
Fractionation of polyalkylene oxide-conjugated hemoglobin solutions
|
IL96477A0
(en)
*
|
1989-12-01 |
1991-08-16 |
Amgen Inc |
Megakaryocyte production
|
SE465222C5
(sv)
|
1989-12-15 |
1998-02-10 |
Pharmacia & Upjohn Ab |
Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
|
US5595900A
(en)
|
1990-02-14 |
1997-01-21 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
US5324663A
(en)
|
1990-02-14 |
1994-06-28 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
DE4009630C2
(de)
|
1990-03-26 |
1995-09-28 |
Reinhard Prof Dr Dr Brossmer |
CMP-aktivierte fluoreszierende Sialinsäuren sowie Verfahren zu ihrer Herstellung
|
US5180674A
(en)
|
1990-04-16 |
1993-01-19 |
The Trustees Of The University Of Pennsylvania |
Saccharide compositions, methods and apparatus for their synthesis
|
US5583042A
(en)
|
1990-04-16 |
1996-12-10 |
Neose Pharmaceuticals, Inc. |
Apparatus for the synthesis of saccharide compositions
|
GB9107846D0
(en)
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
US5951972A
(en)
|
1990-05-04 |
1999-09-14 |
American Cyanamid Company |
Stabilization of somatotropins and other proteins by modification of cysteine residues
|
US5399345A
(en)
|
1990-05-08 |
1995-03-21 |
Boehringer Mannheim, Gmbh |
Muteins of the granulocyte colony stimulating factor
|
US5219564A
(en)
|
1990-07-06 |
1993-06-15 |
Enzon, Inc. |
Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
|
CU22302A1
(es)
|
1990-09-07 |
1995-01-31 |
Cigb |
Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales
|
KR930701601A
(ko)
|
1990-07-10 |
1993-06-12 |
디이터 라우디엔, 루돌프 호프만 |
O-글리코실화 ifn-알파
|
DE4028800A1
(de)
|
1990-09-11 |
1992-03-12 |
Behringwerke Ag |
Gentechnische sialylierung von glykoproteinen
|
US5410016A
(en)
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5529914A
(en)
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
CA2073511A1
(en)
|
1990-11-14 |
1992-05-29 |
Matthew R. Callstrom |
Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
|
US5164374A
(en)
|
1990-12-17 |
1992-11-17 |
Monsanto Company |
Use of oligosaccharides for treatment of arthritis
|
US5861374A
(en)
|
1991-02-28 |
1999-01-19 |
Novo Nordisk A/S |
Modified Factor VII
|
US5833982A
(en)
|
1991-02-28 |
1998-11-10 |
Zymogenetics, Inc. |
Modified factor VII
|
US5788965A
(en)
|
1991-02-28 |
1998-08-04 |
Novo Nordisk A/S |
Modified factor VII
|
HU218890B
(hu)
|
1991-02-28 |
2000-12-28 |
Novo Nordisk A/S |
Véralvadást gátló módosított VII faktorok, ezeket kódoló polinukleotid molekulák, polinukleotid molekulával transzfektált emlős sejtek és a véralvadást gátló módosított VII faktorokat tartalmazó gyógyászati készítmények, valamint a készítmények ...
|
EP0576592B1
(en)
|
1991-03-18 |
2000-05-31 |
The Scripps Research Institute |
Oligosaccharide enzyme substrates and inhibitors: methods and compositions
|
US5278299A
(en)
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
WO1992016555A1
(en)
|
1991-03-18 |
1992-10-01 |
Enzon, Inc. |
Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
|
US5212075A
(en)
|
1991-04-15 |
1993-05-18 |
The Regents Of The University Of California |
Compositions and methods for introducing effectors to pathogens and cells
|
DE69231467T2
(de)
|
1991-05-10 |
2001-01-25 |
Genentech Inc |
Auswählen von agonisten und antagonisten von liganden
|
SE9201544L
(sv)
|
1991-05-31 |
1992-12-01 |
Ciba Geigy Ag |
Saett att framstaella glykosyltransferaser
|
GB2256197B
(en)
|
1991-05-31 |
1995-11-22 |
Ciba Geigy Ag |
Yeast as host for expression of heterologous glycosyl transferase enzymes
|
US5374655A
(en)
|
1991-06-10 |
1994-12-20 |
Alberta Research Council |
Methods for the synthesis of monofucosylated oligosaccharides terminating in di-N-acetyllactosaminyl structures
|
US5352670A
(en)
|
1991-06-10 |
1994-10-04 |
Alberta Research Council |
Methods for the enzymatic synthesis of alpha-sialylated oligosaccharide glycosides
|
KR950014915B1
(ko)
|
1991-06-19 |
1995-12-18 |
주식회사녹십자 |
탈시알로당단백-포함화합물
|
US5281698A
(en)
|
1991-07-23 |
1994-01-25 |
Cetus Oncology Corporation |
Preparation of an activated polymer ester for protein conjugation
|
EP0863154A1
(en)
|
1991-10-12 |
1998-09-09 |
The Regents Of The University Of California |
Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods
|
US6319695B1
(en)
|
1991-10-15 |
2001-11-20 |
The Scripps Research Insitute |
Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
|
US5679777A
(en)
|
1991-11-08 |
1997-10-21 |
Somatogen, Inc. |
Hemoglobins as drug delivery agents
|
US5384249A
(en)
|
1991-12-17 |
1995-01-24 |
Kyowa Hakko Kogyo Co., Ltd. |
α2→3 sialyltransferase
|
IT1260468B
(it)
|
1992-01-29 |
1996-04-09 |
|
Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
|
US5962294A
(en)
|
1992-03-09 |
1999-10-05 |
The Regents Of The University Of California |
Compositions and methods for the identification and synthesis of sialyltransferases
|
DK0632831T3
(da)
|
1992-03-09 |
2003-03-24 |
Univ California |
Nukleinsyre, ekspressionsvektor og sammensætninger til identificering og syntese af rekombinante sialyltransferaser
|
US5858751A
(en)
|
1992-03-09 |
1999-01-12 |
The Regents Of The University Of California |
Compositions and methods for producing sialyltransferases
|
AU3937593A
(en)
|
1992-03-25 |
1993-10-21 |
New York University |
Trans-sialidase and methods of use and making thereof
|
US6037452A
(en)
|
1992-04-10 |
2000-03-14 |
Alpha Therapeutic Corporation |
Poly(alkylene oxide)-Factor VIII or Factor IX conjugate
|
JPH0686684A
(ja)
|
1992-05-26 |
1994-03-29 |
Monsanto Co |
シアロ抱合体の合成
|
US5614184A
(en)
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
WO1994003191A1
(en)
|
1992-08-07 |
1994-02-17 |
Progenics Pharmaceuticals, Inc. |
NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF
|
WO1994004193A1
(en)
|
1992-08-21 |
1994-03-03 |
Enzon, Inc. |
Novel attachment of polyalkylene oxides to bio-effecting substances
|
JP3979678B2
(ja)
|
1992-08-24 |
2007-09-19 |
サントリー株式会社 |
新規糖転移酵素及びそれをコードする遺伝子並びに該酵素の製造方法
|
AU5098193A
(en)
|
1992-09-01 |
1994-03-29 |
Berlex Laboratories, Inc. |
Glycolation of glycosylated macromolecules
|
US5308460A
(en)
|
1992-10-30 |
1994-05-03 |
Glyko, Incorporated |
Rapid synthesis and analysis of carbohydrates
|
US6361977B1
(en)
|
1992-11-24 |
2002-03-26 |
S. Christopher Bauer |
Methods of using multivariant IL-3 hematopoiesis fusion protein
|
JP2845698B2
(ja)
|
1992-11-25 |
1999-01-13 |
オルガノ株式会社 |
復水循環系の復水に含まれる陰イオンの測定方法及び装置
|
JP3202365B2
(ja)
|
1992-12-04 |
2001-08-27 |
株式会社紀文フードケミファ |
オリゴマンヌロン酸を重合度によって分離する方法
|
CA2110543A1
(en)
|
1992-12-09 |
1994-06-10 |
David E. Wright |
Peg hydrazone and peg oxime linkage forming reagents and protein derivatives thereof
|
FI935485A
(fi)
|
1992-12-09 |
1994-06-10 |
Ortho Pharma Corp |
PEG-hydratsoni- ja PEG-oksiimisidoksen muodostavat reagenssit ja niiden proteiinijohdannaiset
|
NZ250375A
(en)
|
1992-12-09 |
1995-07-26 |
Ortho Pharma Corp |
Peg hydrazone and peg oxime linkage forming reagents and protein derivatives
|
WO1994015625A1
(en)
|
1993-01-15 |
1994-07-21 |
Enzon, Inc. |
Factor viii - polymeric conjugates
|
US5349001A
(en)
|
1993-01-19 |
1994-09-20 |
Enzon, Inc. |
Cyclic imide thione activated polyalkylene oxides
|
US5321095A
(en)
|
1993-02-02 |
1994-06-14 |
Enzon, Inc. |
Azlactone activated polyalkylene oxides
|
US5202413A
(en)
|
1993-02-16 |
1993-04-13 |
E. I. Du Pont De Nemours And Company |
Alternating (ABA)N polylactide block copolymers
|
US6180134B1
(en)
|
1993-03-23 |
2001-01-30 |
Sequus Pharmaceuticals, Inc. |
Enhanced ciruclation effector composition and method
|
SG49117A1
(en)
|
1993-03-29 |
1998-05-18 |
Kyowa Hakko Kogyo Kk |
Alfa -1, 3-fucosyltransferase
|
US5409817A
(en)
|
1993-05-04 |
1995-04-25 |
Cytel, Inc. |
Use of trans-sialidase and sialyltransferase for synthesis of sialylα2→3βgalactosides
|
US5374541A
(en)
|
1993-05-04 |
1994-12-20 |
The Scripps Research Institute |
Combined use of β-galactosidase and sialyltransferase coupled with in situ regeneration of CMP-sialic acid for one pot synthesis of oligosaccharides
|
WO1994026906A2
(en)
|
1993-05-14 |
1994-11-24 |
The Upjohn Company |
CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE
|
JPH08510729A
(ja)
|
1993-05-14 |
1996-11-12 |
サイテル コーポレイション |
細胞接着のインヒビターとしてのシアリルLe▲上x▼類似体
|
HU219682B
(hu)
|
1993-05-21 |
2001-06-28 |
Novo Nordisk A/S. |
Módosított VII faktor
|
WO1994028024A1
(en)
|
1993-06-01 |
1994-12-08 |
Enzon, Inc. |
Carbohydrate-modified polymer conjugates with erythropoietic activity
|
US5621039A
(en)
|
1993-06-08 |
1997-04-15 |
Hallahan; Terrence W. |
Factor IX- polymeric conjugates
|
EP0785988A1
(en)
|
1993-07-15 |
1997-07-30 |
Neose Pharmaceuticals, Inc |
Method of synthesizing saccharide compositions
|
DE4325317C2
(de)
|
1993-07-29 |
1998-05-20 |
Univ Dresden Tech |
Verfahren zur radioaktiven Markierung von Immunglobulinen
|
ZA946122B
(en)
|
1993-08-17 |
1995-03-20 |
Amgen Inc |
Erythropoietin analogs
|
JPH0770195A
(ja)
|
1993-08-23 |
1995-03-14 |
Yutaka Mizushima |
糖修飾インターフェロン
|
US6485930B1
(en)
|
1993-09-15 |
2002-11-26 |
The Scripps Research Institute |
Mannosyl transfer with regeneration of GDP-mannose
|
EP0775711B1
(en)
|
1993-09-22 |
2003-03-05 |
Ajinomoto Co., Inc. |
Peptide having antithrombotic activity and process for producing the same
|
US5874075A
(en)
|
1993-10-06 |
1999-02-23 |
Amgen Inc. |
Stable protein: phospholipid compositions and methods
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
US5443953A
(en)
|
1993-12-08 |
1995-08-22 |
Immunomedics, Inc. |
Preparation and use of immunoconjugates
|
US5369017A
(en)
|
1994-02-04 |
1994-11-29 |
The Scripps Research Institute |
Process for solid phase glycopeptide synthesis
|
JP3516272B2
(ja)
|
1994-02-10 |
2004-04-05 |
株式会社成和化成 |
化粧品基材
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US5492841A
(en)
|
1994-02-18 |
1996-02-20 |
E. I. Du Pont De Nemours And Company |
Quaternary ammonium immunogenic conjugates and immunoassay reagents
|
ZA951877B
(en)
|
1994-03-07 |
1996-09-09 |
Dow Chemical Co |
Bioactive and/or targeted dendrimer conjugates
|
IL113010A0
(en)
|
1994-03-31 |
1995-10-31 |
Pharmacia Ab |
Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration
|
US5432059A
(en)
|
1994-04-01 |
1995-07-11 |
Specialty Laboratories, Inc. |
Assay for glycosylation deficiency disorders
|
US5646113A
(en)
|
1994-04-07 |
1997-07-08 |
Genentech, Inc. |
Treatment of partial growth hormone insensitivity syndrome
|
US5629384A
(en)
|
1994-05-17 |
1997-05-13 |
Consiglio Nazionale Delle Ricerche |
Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces
|
US5545553A
(en)
|
1994-09-26 |
1996-08-13 |
The Rockefeller University |
Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
|
EP0785276A4
(en)
|
1994-09-29 |
2002-01-09 |
Ajinomoto Kk |
MODIFICATION OF A PEPTIDE AND A PROTEIN
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
US5834251A
(en)
|
1994-12-30 |
1998-11-10 |
Alko Group Ltd. |
Methods of modifying carbohydrate moieties
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
IL116730A0
(en)
|
1995-01-13 |
1996-05-14 |
Amgen Inc |
Chemically modified interferon
|
SE9501285L
(sv)
|
1995-04-06 |
1996-10-07 |
Johanna Ljung |
Förfarande för framställning av biologiskt aktiva proteiner
|
US6030815A
(en)
|
1995-04-11 |
2000-02-29 |
Neose Technologies, Inc. |
Enzymatic synthesis of oligosaccharides
|
US5728554A
(en)
|
1995-04-11 |
1998-03-17 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
US5922577A
(en)
|
1995-04-11 |
1999-07-13 |
Cytel Corporation |
Enzymatic synthesis of glycosidic linkages
|
WO1996032492A1
(en)
|
1995-04-11 |
1996-10-17 |
Cytel Corporation |
Improved enzymatic synthesis of oligosaccharides
|
US5876980A
(en)
|
1995-04-11 |
1999-03-02 |
Cytel Corporation |
Enzymatic synthesis of oligosaccharides
|
US5695760A
(en)
|
1995-04-24 |
1997-12-09 |
Boehringer Inglehiem Pharmaceuticals, Inc. |
Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
|
CA2227326A1
(en)
|
1995-05-15 |
1996-11-21 |
Philip Dehazya |
Carbohydrate-mediated coupling of peptides to immunoglobulins
|
US6015555A
(en)
|
1995-05-19 |
2000-01-18 |
Alkermes, Inc. |
Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates
|
US5824864A
(en)
|
1995-05-25 |
1998-10-20 |
Pioneer Hi-Bred International, Inc. |
Maize gene and protein for insect control
|
US5858752A
(en)
|
1995-06-07 |
1999-01-12 |
The General Hospital Corporation |
Fucosyltransferase genes and uses thereof
|
US6251864B1
(en)
|
1995-06-07 |
2001-06-26 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
WO1996040731A1
(en)
|
1995-06-07 |
1996-12-19 |
Mount Sinai School Of Medicine Of The City University Of New York |
Pegylated modified proteins
|
US6127153A
(en)
|
1995-06-07 |
2000-10-03 |
Neose Technologies, Inc. |
Method of transferring at least two saccharide units with a polyglycosyltransferase, a polyglycosyltransferase and gene encoding a polyglycosyltransferase
|
US5672662A
(en)
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
CA2227605A1
(en)
|
1995-07-27 |
1997-02-13 |
Richard Barkman Wasser |
Synthetic cationic polymers as promoters for asa sizing
|
US5770420A
(en)
|
1995-09-08 |
1998-06-23 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
PT1568772E
(pt)
|
1995-09-21 |
2010-04-14 |
Genentech Inc |
Variantes da hormona do crescimento humana
|
SE9503380D0
(sv)
|
1995-09-29 |
1995-09-29 |
Pharmacia Ab |
Protein derivatives
|
CA2165041C
(en)
|
1995-12-12 |
2005-07-05 |
The University Of British Columbia |
Methods and compositions for synthesis of oligosaccharides, and the products formed thereby
|
US5716812A
(en)
|
1995-12-12 |
1998-02-10 |
The University Of British Columbia |
Methods and compositions for synthesis of oligosaccharides, and the products formed thereby
|
WO1997021822A2
(en)
|
1995-12-12 |
1997-06-19 |
The University Of British Columbia |
Methods and compositions for synthesis of oligosaccharides using mutant glycosidase enzymes
|
JP3065925B2
(ja)
|
1996-01-30 |
2000-07-17 |
日清製油株式会社 |
活性酸素種消去剤及び退色防止剤
|
DE69738368T2
(de)
|
1996-03-08 |
2008-12-04 |
The Regents Of The University Of Michigan, Ann Arbor |
MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
|
BR9711009A
(pt)
|
1996-08-02 |
1999-08-17 |
Ortho Mcneil Pharm Inc |
Polipeptidio tendo um polimero solÚvel em gua n-terminal covalentemente ligado
|
EP0953354A4
(en)
*
|
1996-08-13 |
2002-10-23 |
Fujisawa Pharmaceutical Co |
HEMATOPOIETIC STEM CELLS PROLIFERING ACTIVE SUBSTANCES
|
US20020064546A1
(en)
|
1996-09-13 |
2002-05-30 |
J. Milton Harris |
Degradable poly(ethylene glycol) hydrogels with controlled half-life and precursors therefor
|
CA2268168C
(en)
|
1996-10-10 |
2008-04-29 |
Cytel Corporation |
Carbohydrate purification using ultrafiltration, reverse osmosis and nanofiltration
|
CA2276267C
(en)
|
1996-10-15 |
2009-12-22 |
The Liposome Company, Inc. |
Peptide-lipid conjugates, liposomes and liposomal drug delivery
|
WO1998020111A1
(en)
|
1996-11-08 |
1998-05-14 |
Cytel Corporation |
Improved expression vectors
|
DE69823046T2
(de)
|
1997-01-16 |
2005-03-31 |
Neose Technologies, Inc. |
Praktische in vitro sialylierung von rekombinanten glykpproteinen
|
JP2001508783A
(ja)
|
1997-01-29 |
2001-07-03 |
ポリマスク・ファーマシューティカルズ・パブリック・リミテッド・カンパニー |
Peg化法
|
DE19709787A1
(de)
|
1997-03-11 |
1998-09-17 |
Bayer Ag |
Oligosaccaride und deren Derivate sowie ein chemo-enzymatisches Verfahren zu deren Herstellung
|
US5945314A
(en)
|
1997-03-31 |
1999-08-31 |
Abbott Laboratories |
Process for synthesizing oligosaccharides
|
CA2288994C
(en)
|
1997-04-30 |
2011-07-05 |
Enzon, Inc. |
Polyalkylene oxide-modified single chain polypeptides
|
JPH10307356A
(ja)
|
1997-05-08 |
1998-11-17 |
Konica Corp |
ハロゲン化銀乳剤およびそれを用いたハロゲン化銀写真感光材料
|
US6183738B1
(en)
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
US6075134A
(en)
|
1997-05-15 |
2000-06-13 |
The Regents Of The University Of California |
Glycoconjugates and methods
|
WO1998055630A2
(en)
|
1997-06-06 |
1998-12-10 |
The Governors Of The University Of Alberta |
Alpha-1,3-fucosyltransferase of helicobacter pylori
|
PT994903E
(pt)
|
1997-06-24 |
2005-10-31 |
Genentech Inc |
Metodos e composicoes para glicoproteinas galactosiladas
|
WO1999000150A2
(en)
|
1997-06-27 |
1999-01-07 |
Regents Of The University Of California |
Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptor
|
US20030027257A1
(en)
|
1997-08-21 |
2003-02-06 |
University Technologies International, Inc. |
Sequences for improving the efficiency of secretion of non-secreted protein from mammalian and insect cells
|
WO1999013063A1
(en)
|
1997-09-09 |
1999-03-18 |
Nycomed Imaging As |
Factor vii fragments and analogs thereof and their use in the treatment of blood clottng disorders
|
AU759779B2
(en)
|
1997-10-31 |
2003-05-01 |
Genentech Inc. |
Methods and compositions comprising glycoprotein glycoforms
|
CA2312843A1
(en)
|
1997-12-01 |
1999-06-10 |
Neose Technologies Inc. |
Enzymatic synthesis of gangliosides
|
EP0924298A1
(en)
|
1997-12-18 |
1999-06-23 |
Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) |
Protein expression in baculovirus vector expression systems
|
DK1053019T3
(da)
|
1998-01-07 |
2004-04-13 |
Debio Rech Pharma Sa |
Nedbrydelige heterobifunktionelle polyethylenglycolacrylater og geler og konjugater afledt derfra
|
WO1999037779A1
(en)
|
1998-01-22 |
1999-07-29 |
Genentech, Inc. |
Antibody fragment-polymer conjugates and humanized anti-il-8 monoclonal antibodies and uses of same
|
WO1999045964A1
(en)
|
1998-03-12 |
1999-09-16 |
Shearwater Polymers, Incorporated |
Poly(ethylene glycol) derivatives with proximal reactive groups
|
AU758097B2
(en)
|
1998-03-25 |
2003-03-13 |
Sloan-Kettering Institute For Cancer Research |
Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereof
|
ATE458007T1
(de)
|
1998-04-20 |
2010-03-15 |
Glycart Biotechnology Ag |
Glykosylierungs-engineering von antikörpern zur verbesserung der antikörperabhängigen zellvermittelten zytotoxizität
|
IL139285A0
(en)
|
1998-04-28 |
2001-11-25 |
Applied Research Systems |
Peg-lhrh analog conjugates, their preparation and use
|
US20030166525A1
(en)
|
1998-07-23 |
2003-09-04 |
Hoffmann James Arthur |
FSH Formulation
|
CZ299164B6
(cs)
|
1998-10-16 |
2008-05-07 |
Biogen Idec Ma Inc. |
Farmaceutická kompozice obsahující glykosylovaný interferon-beta-1a navázaný na polymer
|
US7304150B1
(en)
|
1998-10-23 |
2007-12-04 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
CN1325443A
(zh)
|
1998-10-30 |
2001-12-05 |
诺沃奇梅兹有限公司 |
具有减弱的变应原性的糖基化蛋白
|
CA2350079A1
(en)
|
1998-11-13 |
2000-05-25 |
Henrick Clausen |
Udp-galactose: beta-n-acetyl-glucosamine beta1,3galactosyltransferases. beta3gal-t5
|
DE19852729A1
(de)
|
1998-11-16 |
2000-05-18 |
Werner Reutter |
Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
|
AU773845B2
(en)
|
1998-11-18 |
2004-06-10 |
Neose Technologies, Inc. |
Low cost manufacture of oligosaccharides
|
US6465220B1
(en)
|
1998-12-21 |
2002-10-15 |
Glycozym Aps |
Glycosylation using GalNac-T4 transferase
|
EP1157037B1
(en)
|
1999-01-29 |
2003-07-30 |
F. Hoffmann-La Roche Ag |
Gcsf conjugates
|
US6503744B1
(en)
|
1999-02-01 |
2003-01-07 |
National Research Council Of Canada |
Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
|
US6949372B2
(en)
|
1999-03-02 |
2005-09-27 |
The Johns Hopkins University |
Engineering intracellular sialylation pathways
|
JP2002542792A
(ja)
|
1999-04-22 |
2002-12-17 |
アストラゼネカ アクチボラグ |
ホスホ−n−アセチルムラミル−ペンタペプチド転移酵素活性を検出するためのアッセイ
|
JO2291B1
(en)
|
1999-07-02 |
2005-09-12 |
اف . هوفمان لاروش ايه جي |
Erythropoietin derivatives
|
US6261805B1
(en)
|
1999-07-15 |
2001-07-17 |
Boyce Thompson Institute For Plant Research, Inc. |
Sialyiation of N-linked glycoproteins in the baculovirus expression vector system
|
WO2001005434A2
(en)
|
1999-07-20 |
2001-01-25 |
Amgen Inc. |
Hyaluronic acid-protein conjugates
|
US6642038B1
(en)
|
1999-09-14 |
2003-11-04 |
Genzyme Glycobiology Research Institute, Inc. |
GlcNAc phosphotransferase of the lysosomal targeting pathway
|
US6716626B1
(en)
|
1999-11-18 |
2004-04-06 |
Chiron Corporation |
Human FGF-21 nucleic acids
|
ES2377935T3
(es)
|
1999-12-02 |
2012-04-03 |
Zymogenetics, Inc. |
Procedimiento para dirigir células que expresan receptor -3 o -2 del factor de crecimiento de fibroblastos
|
US6348558B1
(en)
|
1999-12-10 |
2002-02-19 |
Shearwater Corporation |
Hydrolytically degradable polymers and hydrogels made therefrom
|
DK1259563T4
(en)
|
1999-12-22 |
2016-11-21 |
Nektar Therapeutics |
PROCEDURE FOR PREPARING 1-BENZOTRIAZOLYL CARBONATE ESTERS OF WATER SOLUBLE POLYMERS
|
WO2001048052A1
(fr)
|
1999-12-24 |
2001-07-05 |
Kyowa Hakko Kogyo Co., Ltd. |
Glycols de polyalkylene ramifies
|
IL150314A0
(en)
|
1999-12-30 |
2002-12-01 |
Maxygen Aps |
Improved lysosomal enzymes and lysosomal enzyme activators
|
US6555660B2
(en)
|
2000-01-10 |
2003-04-29 |
Maxygen Holdings Ltd. |
G-CSF conjugates
|
ATE435033T1
(de)
|
2000-01-10 |
2009-07-15 |
Maxygen Holdings Ltd |
G-csf konjugate
|
US6646110B2
(en)
|
2000-01-10 |
2003-11-11 |
Maxygen Holdings Ltd. |
G-CSF polypeptides and conjugates
|
WO2001058493A1
(en)
|
2000-02-11 |
2001-08-16 |
Maxygen Aps |
Conjugates of follicle stimulating hormones
|
PL206148B1
(pl)
|
2000-02-11 |
2010-07-30 |
Bayer HealthCare LLCBayer HealthCare LLC |
Koniugat polipeptydowy, polipeptyd, sekwencja nukleotydowa, wektor ekspresyjny, komórka gospodarz, sposób wytwarzania koniugatu polipeptydowego, środek farmaceutyczny i zastosowanie koniugatu polipeptydowego
|
AU2001232337A1
(en)
|
2000-02-18 |
2001-08-27 |
Kanagawa Academy Of Science And Technology |
Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance
|
US20010041683A1
(en)
|
2000-03-09 |
2001-11-15 |
Schmitz Harold H. |
Cocoa sphingolipids, cocoa extracts containing sphingolipids and methods of making and using same
|
ATE329925T1
(de)
|
2000-03-16 |
2006-07-15 |
Univ California |
Chemoselektive anknüpfung durch verwendung eines phosphins
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
US6905683B2
(en)
|
2000-05-03 |
2005-06-14 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII variants
|
ATE485371T1
(de)
|
2000-05-03 |
2010-11-15 |
Novo Nordisk Healthcare Ag |
Varianten des menschlichen koagulationsfaktors vii
|
US7338932B2
(en)
|
2000-05-11 |
2008-03-04 |
Glycozym Aps |
Methods of modulating functions of polypeptide GalNAc-transferases and of screening test substances to find agents herefor, pharmaceutical compositions comprising such agents and the use of such agents for preparing medicaments
|
US20020019342A1
(en)
|
2000-05-12 |
2002-02-14 |
Robert Bayer |
In vitro modification of glycosylation patterns of recombinant glycopeptides
|
CN1309416C
(zh)
|
2000-05-15 |
2007-04-11 |
霍夫曼-拉罗奇有限公司 |
新的药物组合物
|
EP1284987B1
(en)
|
2000-05-16 |
2007-07-18 |
Bolder Biotechnology, Inc. |
Methods for refolding proteins containing free cysteine residues
|
MXPA03000105A
(es)
|
2000-06-28 |
2004-09-13 |
Glycofi Inc |
Metodo para producir glicoproteinas modificadas.
|
JP2004504016A
(ja)
|
2000-06-30 |
2004-02-12 |
マキシゲン・エイピーエス |
ペプチド拡張されたグリコシル化ポリペプチド
|
US6423826B1
(en)
|
2000-06-30 |
2002-07-23 |
Regents Of The University Of Minnesota |
High molecular weight derivatives of vitamin K-dependent polypeptides
|
KR100396983B1
(ko)
|
2000-07-29 |
2003-09-02 |
이강춘 |
고반응성의 가지 달린 고분자 유도체 및 고분자와 단백질또는 펩타이드의 접합체
|
AU2001285020A1
(en)
|
2000-08-17 |
2002-02-25 |
Synapse Technologies, Inc. |
P97-active agent conjugates and their methods of use
|
WO2002013843A2
(en)
|
2000-08-17 |
2002-02-21 |
University Of British Columbia |
Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
|
US20020151471A1
(en)
|
2000-10-02 |
2002-10-17 |
Pingel Hans Kurt |
Factor VII glycoforms
|
US20020142964A1
(en)
|
2000-11-02 |
2002-10-03 |
Nissen Torben Lauesgaard |
Single-chain polypeptides
|
CA2416054A1
(en)
|
2000-11-27 |
2002-06-27 |
Rmf Dictagene S.A. |
Process for folding chemically synthesized polypeptides
|
WO2002044196A1
(en)
|
2000-11-28 |
2002-06-06 |
University Of Massachusetts |
Methods and reagents for introducing a sulfhydryl group into the 5'-terminus of rna
|
ES2361824T3
(es)
|
2000-12-20 |
2011-06-22 |
F. Hoffmann-La Roche Ag |
Conjugados de eritropoyetina (epo) con polietilenglicol (peg).
|
EP1345628B1
(en)
|
2000-12-20 |
2011-04-13 |
F. Hoffmann-La Roche AG |
Conjugates of erythropoietin (epo) with polyethylene glycol (peg)
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
PA8536201A1
(es)
|
2000-12-29 |
2002-08-29 |
Kenneth S Warren Inst Inc |
Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina
|
US6531121B2
(en)
|
2000-12-29 |
2003-03-11 |
The Kenneth S. Warren Institute, Inc. |
Protection and enhancement of erythropoietin-responsive cells, tissues and organs
|
SE0004932D0
(sv)
|
2000-12-31 |
2000-12-31 |
Apbiotech Ab |
A method for mixed mode adsorption and mixed mode adsorbents
|
IL156059A0
(en)
|
2001-02-27 |
2003-12-23 |
Maxygen Aps |
NEW INTERFERON beta-LIKE MOLECULES
|
US7235638B2
(en)
|
2001-03-22 |
2007-06-26 |
Novo Nordisk Healthcare A/G |
Coagulation factor VII derivatives
|
CN100567487C
(zh)
|
2001-03-22 |
2009-12-09 |
诺沃挪第克健康护理股份公司 |
凝血因子vii衍生物
|
HUP0400284A3
(en)
|
2001-05-03 |
2012-09-28 |
Merck Patent Gmbh |
Recombinant tumor specific antibody and use thereof
|
EP1392350A2
(en)
|
2001-05-11 |
2004-03-03 |
Aradigm Corporation |
Optimization of the molecular properties and formulation of proteins delivered by inhalation
|
AU2002342653A1
(en)
|
2001-05-14 |
2002-11-25 |
The Gouvernment Of The United States Of America, Represented By The Secretary, Department Of Health |
Modified growth hormone
|
MXPA04000231A
(es)
|
2001-07-11 |
2004-05-04 |
Maxygen Holdings Ltd |
Conjugados del factor de estimulacion de colonias de granulocitos.
|
KR100453877B1
(ko)
|
2001-07-26 |
2004-10-20 |
메덱스젠 주식회사 |
연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 TNFR/Fc 융합 단백질, 상기 단백질을 코딩하는 DNA, 상기 DNA를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
|
JP2005501837A
(ja)
|
2001-08-01 |
2005-01-20 |
ネオーズ テクノロジーズ, インコーポレイテッド |
中性スフィンゴ糖脂質およびグリコシルスフィンゴシンおよびそれらを単離する方法
|
NZ531093A
(en)
|
2001-08-17 |
2007-12-21 |
Neose Technologies Inc |
Chemo-enzymatic synthesis of sialylated oligosaccharides
|
EP1435972B1
(en)
|
2001-08-29 |
2016-03-09 |
Seneb Biosciences Inc. |
Novel synthetic ganglioside derivatives and compositions thereof
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
US7052868B2
(en)
|
2001-09-27 |
2006-05-30 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII polypeptides
|
US7399613B2
(en)
|
2001-10-10 |
2008-07-15 |
Neose Technologies, Inc. |
Sialic acid nucleotide sugars
|
US7173003B2
(en)
|
2001-10-10 |
2007-02-06 |
Neose Technologies, Inc. |
Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
|
US7157277B2
(en)
|
2001-11-28 |
2007-01-02 |
Neose Technologies, Inc. |
Factor VIII remodeling and glycoconjugation of Factor VIII
|
US7297511B2
(en)
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
US7439043B2
(en)
|
2001-10-10 |
2008-10-21 |
Neose Technologies, Inc. |
Galactosyl nucleotide sugars
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
US7265084B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7179617B2
(en)
|
2001-10-10 |
2007-02-20 |
Neose Technologies, Inc. |
Factor IX: remolding and glycoconjugation of Factor IX
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
US7226903B2
(en)
|
2001-10-10 |
2007-06-05 |
Neose Technologies, Inc. |
Interferon beta: remodeling and glycoconjugation of interferon beta
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7696163B2
(en)
|
2001-10-10 |
2010-04-13 |
Novo Nordisk A/S |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
ES2564688T3
(es)
|
2001-10-10 |
2016-03-28 |
Ratiopharm Gmbh |
Remodelación y glicoconjugación de poli(éter) a eritropoyetina
|
US8008252B2
(en)
|
2001-10-10 |
2011-08-30 |
Novo Nordisk A/S |
Factor VII: remodeling and glycoconjugation of Factor VII
|
US7265085B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycoconjugation methods and proteins/peptides produced by the methods
|
US6784154B2
(en)
|
2001-11-01 |
2004-08-31 |
University Of Utah Research Foundation |
Method of use of erythropoietin to treat ischemic acute renal failure
|
AU2002351197A1
(en)
|
2001-11-28 |
2003-06-10 |
Neose Technologies, Inc. |
Glycopeptide remodeling using amidases
|
AU2002351199A1
(en)
|
2001-11-28 |
2003-06-10 |
Neose Technologies, Inc. |
Glycoprotein remodeling using endoglycanases
|
US7473680B2
(en)
|
2001-11-28 |
2009-01-06 |
Neose Technologies, Inc. |
Remodeling and glycoconjugation of peptides
|
US20060035224A1
(en)
|
2002-03-21 |
2006-02-16 |
Johansen Jack T |
Purification methods for oligonucleotides and their analogs
|
US7569376B2
(en)
|
2002-05-03 |
2009-08-04 |
Neose Technologies, Inc. |
Fucosyltransferase fusion protein
|
DE60336555D1
(de)
|
2002-06-21 |
2011-05-12 |
Novo Nordisk Healthcare Ag |
Pegylierte glykoformen von faktor vii
|
AU2003240439B2
(en)
|
2002-06-21 |
2009-05-21 |
Novo Nordisk Health Care Ag |
Pegylated factor VII glycoforms
|
DE10232916B4
(de)
|
2002-07-19 |
2008-08-07 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Vorrichtung und Verfahren zum Charakterisieren eines Informationssignals
|
WO2004009838A2
(en)
|
2002-07-23 |
2004-01-29 |
Neose Technologies, Inc. |
H. Pylori FUCOSYLTRANSFERASES
|
CN1671722A
(zh)
|
2002-08-01 |
2005-09-21 |
加拿大国家研究院 |
弯曲菌的聚糖和糖肽
|
CA2493977A1
(en)
|
2002-08-02 |
2004-02-19 |
Glaxosmithkline Biologicals Sa |
Vaccine composition comprising lipooligosaccharide with reduced phase variability
|
MXPA05002476A
(es)
|
2002-09-05 |
2005-10-19 |
Gi Company Inc |
Asialo-interferones modificados y sus usos.
|
JP2006501820A
(ja)
|
2002-09-06 |
2006-01-19 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
修飾glp−1受容体アゴニストおよびそれらの薬理学的使用法
|
WO2005025606A1
(en)
|
2003-09-09 |
2005-03-24 |
Warren Pharmaceuticals, Inc. |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
CN1703421B
(zh)
|
2002-09-20 |
2010-06-23 |
法玛西亚公司 |
降低peg化蛋白的聚集体水平的方法
|
EP1546202B1
(en)
|
2002-09-25 |
2007-08-22 |
Novo Nordisk Health Care AG |
Human coagulation factor vii polypeptides
|
US20040062748A1
(en)
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
DK1549677T3
(da)
|
2002-09-30 |
2011-07-18 |
Bayer Healthcare Llc |
FVII- eller FVIIa-varianter med forøget koagulationsaktivitet
|
NZ539415A
(en)
|
2002-10-09 |
2008-12-24 |
Neose Technologies Inc |
Remodelling and glycoconjugation of erythropoietin
|
DE60314658D1
(de)
|
2002-11-08 |
2007-08-09 |
Glycozym Aps |
Verfahren zur identifizierung von die funktionen von polypeptid-galnac-transferasen modulierenden agentien, solche agentien umfassende pharmazeutische zusammensetzungen und verwendung solcher agentien zur herstellung von arzneimitteln
|
JP4412461B2
(ja)
|
2002-11-20 |
2010-02-10 |
日油株式会社 |
修飾された生体関連物質、その製造方法および中間体
|
US7459436B2
(en)
|
2002-11-22 |
2008-12-02 |
Hoffmann-La Roche Inc. |
Treatment of disturbances of iron distribution
|
US20050064540A1
(en)
|
2002-11-27 |
2005-03-24 |
Defrees Shawn Ph.D |
Glycoprotein remodeling using endoglycanases
|
EP1424344A1
(en)
|
2002-11-29 |
2004-06-02 |
Aventis Behring Gesellschaft mit beschränkter Haftung |
Modified cDNA factor VIII and its derivates
|
DE60228460D1
(de)
|
2002-12-13 |
2008-10-02 |
Bioceuticals Arzneimittel Ag |
Verfahren zur Herstellung und Reinigung von Erythropoietin
|
PT1667708E
(pt)
|
2002-12-26 |
2012-09-14 |
Mountain View Pharmaceuticals |
Conjugados de interferão-beta-1b e polietileno glicol apresentando uma potência biológica in vitro aumentada
|
US7041635B2
(en)
|
2003-01-28 |
2006-05-09 |
In2Gen Co., Ltd. |
Factor VIII polypeptide
|
KR101085375B1
(ko)
|
2003-02-26 |
2011-11-21 |
넥타르 테라퓨틱스 |
중합체-인자 ⅷ 부분 콘쥬게이트
|
BRPI0408358A
(pt)
|
2003-03-14 |
2006-03-21 |
Neose Technologies Inc |
polìmeros hidrossolúveis ramificados e seus conjugados
|
EP1603954A4
(en)
|
2003-03-18 |
2006-04-12 |
Neose Technologies Inc |
ACTIVATED FORMS OF WATER SOLUBLE POLYMERS
|
CN1832959A
(zh)
|
2003-03-19 |
2006-09-13 |
伊莱利利公司 |
聚乙二醇连接的glp-1化合物
|
US8791070B2
(en)
|
2003-04-09 |
2014-07-29 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
WO2006127896A2
(en)
|
2005-05-25 |
2006-11-30 |
Neose Technologies, Inc. |
Glycopegylated factor ix
|
US20130344050A1
(en)
|
2003-04-09 |
2013-12-26 |
Novo Nordisk A/S |
Glycopegylated Factor IX
|
EP2338333B1
(en)
|
2003-04-09 |
2017-09-06 |
ratiopharm GmbH |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7691603B2
(en)
|
2003-04-09 |
2010-04-06 |
Novo Nordisk A/S |
Intracellular formation of peptide conjugates
|
US7718363B2
(en)
|
2003-04-25 |
2010-05-18 |
The Kenneth S. Warren Institute, Inc. |
Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
DE602004031390D1
(de)
|
2003-05-06 |
2011-03-24 |
Syntonix Pharmaceuticals Inc |
Gerinnungsfaktor VII-Fc chimäre Proteine zur Behandlung von hämostatischen Krankheiten
|
ES2380093T3
(es)
|
2003-05-09 |
2012-05-08 |
Biogenerix Ag |
Composiciones y métodos para la preparación de mutantes de glucosilación de la hormona del crecimiento humana
|
WO2004101597A2
(en)
|
2003-05-13 |
2004-11-25 |
Frutarom Ltd. |
Methods for the reduction of disulfide bonds
|
US7074755B2
(en)
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
EP1481985A1
(en)
|
2003-05-28 |
2004-12-01 |
Innogenetics N.V. |
Modified hepatitis C virus (HCV) NS3 for medical treatment
|
GB0315457D0
(en)
|
2003-07-01 |
2003-08-06 |
Celltech R&D Ltd |
Biological products
|
US9005625B2
(en)
|
2003-07-25 |
2015-04-14 |
Novo Nordisk A/S |
Antibody toxin conjugates
|
US20060198819A1
(en)
|
2003-08-08 |
2006-09-07 |
Novo Nordisk Healthcare A/G |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
WO2005014049A2
(en)
|
2003-08-08 |
2005-02-17 |
Novo Nordisk A/S |
Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides
|
WO2005014024A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of a polymer and a protein linked by an oxime linking group
|
US7524813B2
(en)
|
2003-10-10 |
2009-04-28 |
Novo Nordisk Health Care Ag |
Selectively conjugated peptides and methods of making the same
|
US20080305992A1
(en)
|
2003-11-24 |
2008-12-11 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
WO2005072371A2
(en)
|
2004-01-26 |
2005-08-11 |
Neose Technologies, Inc. |
Branched polymeric sugars and nucleotides thereof
|
JP4719686B2
(ja)
|
2003-11-24 |
2011-07-06 |
バイオジェネリックス アーゲー |
GlycoPEG化エリスロポエチン
|
US20080318850A1
(en)
|
2003-12-03 |
2008-12-25 |
Neose Technologies, Inc. |
Glycopegylated Factor Ix
|
WO2005056760A2
(en)
|
2003-12-03 |
2005-06-23 |
Neose Technologies, Inc. |
Glycopegylated follicle stimulating hormone
|
AU2004296860B2
(en)
|
2003-12-03 |
2010-04-22 |
Novo Nordisk A/S |
Glycopegylated factor IX
|
US7956032B2
(en)
*
|
2003-12-03 |
2011-06-07 |
Novo Nordisk A/S |
Glycopegylated granulocyte colony stimulating factor
|
KR101237884B1
(ko)
|
2003-12-03 |
2013-02-27 |
바이오제너릭스 에이지 |
글리코 peg화 과립구 콜로니 자극인자
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
AU2005206796B2
(en)
|
2004-01-08 |
2011-06-16 |
Ratiopharm Gmbh |
O-linked glycosylation of peptides
|
US20080058245A1
(en)
|
2004-01-09 |
2008-03-06 |
Johnson Karl F |
Vectors for Recombinant Protein Expression in E. Coli
|
US20070105770A1
(en)
|
2004-01-21 |
2007-05-10 |
Novo Nordisk A/S |
Transglutaminase mediated conjugation of peptides
|
TR201808488T4
(tr)
|
2004-02-12 |
2018-07-23 |
Archemix Llc |
Komplemana bağlı bozuklukların tedavisinde yararlı aptamer terapötikleri.
|
CA2557782A1
(en)
|
2004-03-17 |
2005-10-06 |
Eli Lilly And Company |
Glycol linked fgf-21 compounds
|
MXPA06012676A
(es)
|
2004-05-04 |
2007-04-02 |
Novo Nordisk Healthcare Ag |
Glucoformas o-enlazadas de polipeptidos y metodos de fabricacion de los mismos.
|
US20070037966A1
(en)
|
2004-05-04 |
2007-02-15 |
Novo Nordisk A/S |
Hydrophobic interaction chromatography purification of factor VII polypeptides
|
JP4251399B2
(ja)
|
2004-05-21 |
2009-04-08 |
独立行政法人産業技術総合研究所 |
O結合型糖鎖が付加されたペプチドのスクリーニング方法
|
EP1765992A4
(en)
|
2004-06-03 |
2009-01-07 |
Neose Technologies Inc |
SHORTEN GALNACT2 POLYPEPTIDES AND NUCLEIC ACIDS
|
US20080206810A1
(en)
|
2004-06-03 |
2008-08-28 |
Neose Technologies, Inc. |
Truncated St6galnaci Polypeptides and Nucleic Acids
|
JP2008505119A
(ja)
|
2004-06-30 |
2008-02-21 |
ネクター セラピューティクス アラバマ,コーポレイション |
高分子−第ix因子部分の抱合体
|
CA2572751A1
(en)
|
2004-06-30 |
2006-01-12 |
Egen Corporation |
Pegylated interferon alpha-1b
|
EP1771190A4
(en)
|
2004-07-02 |
2009-07-22 |
Kenneth S Warren Inst Inc |
METHOD FOR THE PRODUCTION OF COMPLETELY CARBAMYLATED ERYTHROPOIETIN
|
WO2006014466A2
(en)
|
2004-07-02 |
2006-02-09 |
The Kenneth S. Warren Institute, Inc. |
Novel carbamylated epo and method for its production
|
US20080300173A1
(en)
|
2004-07-13 |
2008-12-04 |
Defrees Shawn |
Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1]
|
WO2006020372A2
(en)
|
2004-07-23 |
2006-02-23 |
Neose Technologies, Inc. |
Enzymatic modification of glycopeptides
|
SE0401951D0
(sv)
|
2004-07-29 |
2004-07-29 |
Amersham Biosciences Ab |
Chromatography method
|
US20060024286A1
(en)
|
2004-08-02 |
2006-02-02 |
Paul Glidden |
Variants of tRNA synthetase fragments and uses thereof
|
EP1778838A2
(en)
|
2004-08-02 |
2007-05-02 |
Novo Nordisk Health Care AG |
Conjugation of fvii
|
EP1781782B1
(en)
|
2004-08-17 |
2010-05-26 |
CSL Behring GmbH |
Modified vitamin k dependent polypeptides
|
EP1799249A2
(en)
|
2004-09-10 |
2007-06-27 |
Neose Technologies, Inc. |
Glycopegylated interferon alpha
|
WO2006035057A1
(en)
|
2004-09-29 |
2006-04-06 |
Novo Nordisk Health Care Ag |
Modified proteins
|
JP5948627B2
(ja)
|
2004-10-29 |
2016-07-20 |
レイショファーム ゲーエムベーハー |
線維芽細胞成長因子(fgf)のリモデリングと糖質ペグ化
|
LT1824988T
(lt)
|
2004-11-12 |
2017-10-25 |
Bayer Healthcare Llc |
Nukreipta į užduotą saitą fviii modifikacija
|
WO2006066258A2
(en)
|
2004-12-17 |
2006-06-22 |
Neose Technologies, Inc. |
Lipoconjugation of peptides
|
AU2005323106B2
(en)
|
2004-12-22 |
2010-07-29 |
Ambrx, Inc. |
Methods for expression and purification of recombinant human growth hormone
|
EP1838332A1
(en)
|
2005-01-06 |
2007-10-03 |
Neose Technologies, Inc. |
Glycoconjugation using saccharyl fragments
|
EP2514757A3
(en)
|
2005-01-10 |
2014-03-05 |
ratiopharm GmbH |
Glycopegylated granulocyte colony stimulating factor
|
WO2006078645A2
(en)
|
2005-01-19 |
2006-07-27 |
Neose Technologies, Inc. |
Heterologous polypeptide expression using low multiplicity of infection of viruses
|
PA8660701A1
(es)
|
2005-02-04 |
2006-09-22 |
Pfizer Prod Inc |
Agonistas de pyy y sus usos
|
MX2007011801A
(es)
|
2005-03-24 |
2008-02-19 |
Neose Technologies Inc |
Expresion de glicosiltransferasas eucarioticas activas, solubles en organismos procarioticos.
|
EP1866427A4
(en)
|
2005-03-30 |
2010-09-01 |
Novo Nordisk As |
MANUFACTURING PROCESS FOR THE PRODUCTION OF CULTIVE PEPTIDES IN CELL LINES OF INSECTS
|
US20080227691A1
(en)
|
2005-04-01 |
2008-09-18 |
Novo Nordisk Health Care Ag |
Blood Coagulation FVIII Analogues
|
US9187546B2
(en)
|
2005-04-08 |
2015-11-17 |
Novo Nordisk A/S |
Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
|
PT1888761E
(pt)
|
2005-05-11 |
2011-01-03 |
Eth Zuerich |
Proteínas n-glicosiladas recombinantes de células procarióticas
|
EP1888098A2
(en)
|
2005-05-25 |
2008-02-20 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin formulations
|
US20110003744A1
(en)
|
2005-05-25 |
2011-01-06 |
Novo Nordisk A/S |
Glycopegylated Erythropoietin Formulations
|
JP5335422B2
(ja)
|
2005-06-17 |
2013-11-06 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
少なくとも1つの非天然のシステインを含んでいる操作されたタンパク質の選択的な還元および誘導体化
|
AU2006280932A1
(en)
|
2005-08-19 |
2007-02-22 |
Novo Nordisk A/S |
Glycopegylated factor VII and factor Vila
|
US20070105755A1
(en)
|
2005-10-26 |
2007-05-10 |
Neose Technologies, Inc. |
One pot desialylation and glycopegylation of therapeutic peptides
|
WO2007031559A2
(en)
|
2005-09-14 |
2007-03-22 |
Novo Nordisk Health Care Ag |
Human coagulation factor vii polypeptides
|
WO2007056191A2
(en)
|
2005-11-03 |
2007-05-18 |
Neose Technologies, Inc. |
Nucleotide sugar purification using membranes
|
DE102006009437A1
(de)
|
2006-03-01 |
2007-09-13 |
Bioceuticals Arzneimittel Ag |
G-CSF-Flüssigformulierung
|
US7645860B2
(en)
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
JP2009537609A
(ja)
|
2006-05-24 |
2009-10-29 |
ノボ ノルディスク ヘルス ケア アーゲー |
延長されたfixアナログ及び誘導体
|
WO2008011633A2
(en)
|
2006-07-21 |
2008-01-24 |
Neose Technologies, Inc. |
Glycosylation of peptides via o-linked glycosylation sequences
|
ITMI20061624A1
(it)
|
2006-08-11 |
2008-02-12 |
Bioker Srl |
Mono-coniugati sito-specifici di g-csf
|
ES2531934T3
(es)
|
2006-09-01 |
2015-03-20 |
Novo Nordisk Health Care Ag |
Glicoproteínas modificadas
|
US20100075375A1
(en)
|
2006-10-03 |
2010-03-25 |
Novo Nordisk A/S |
Methods for the purification of polypeptide conjugates
|
EP2068907B1
(en)
|
2006-10-04 |
2017-11-29 |
Novo Nordisk A/S |
Glycerol linked pegylated sugars and glycopeptides
|
WO2008073620A2
(en)
|
2006-11-02 |
2008-06-19 |
Neose Technologies, Inc. |
Manufacturing process for the production of polypeptides expressed in insect cell-lines
|
KR20100016160A
(ko)
|
2007-04-03 |
2010-02-12 |
바이오제너릭스 에이지 |
글리코페길화 g―csf를 이용하는 치료 방법
|
US20090053167A1
(en)
|
2007-05-14 |
2009-02-26 |
Neose Technologies, Inc. |
C-, S- and N-glycosylation of peptides
|
US20110177029A1
(en)
|
2007-06-04 |
2011-07-21 |
Novo Nordisk A/S |
O-linked glycosylation using n-acetylglucosaminyl transferases
|
JP5876649B2
(ja)
|
2007-06-12 |
2016-03-02 |
ラツィオファルム ゲーエムベーハーratiopharm GmbH |
ヌクレオチド糖の改良製造法
|
US8207112B2
(en)
|
2007-08-29 |
2012-06-26 |
Biogenerix Ag |
Liquid formulation of G-CSF conjugate
|
EP2242505A4
(en)
|
2008-01-08 |
2012-03-07 |
Biogenerix Ag |
GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
|